Additional Information

Description

Verapamil 2.5 mg/mL Injection, supplied in a 4 mL single-dose glass flip-top vial, is a calcium channel blocker used in the management of cardiovascular conditions. It works by inhibiting the influx of calcium ions across cardiac and vascular smooth muscle cell membranes, leading to vasodilation, decreased myocardial contractility, and a reduction in heart rate.

Each milliliter of the solution contains 2.5 mg of verapamil hydrochloride in a sterile, isotonic base suitable for intravenous administration. The single-dose vial ensures sterility and is intended for one-time use, reducing the risk of contamination. Verapamil is particularly useful in the acute management of supraventricular tachycardia and the control of ventricular rate in patients with atrial fibrillation or flutter.

The glass flip-top vial is designed to maintain product stability and sterility until the point of use. The solution is clear and colorless, and healthcare providers should inspect it for particulate matter or discoloration before administration. Proper dosing must be calculated based on the patient's condition, weight, and response to therapy, with close monitoring for adverse effects.